撞击综合征市场 - 全球行业规模、份额、趋势、机会和预测，按肌肉骨骼疾病类型、按诊断和成像技术、按治疗方式、按最终用户、按地区和竞争进行细分，2020-2030 年预测

2024 年全球撞击症候群市场价值为 81.2 亿美元，预计到 2030 年将达到 125.1 亿美元，预测期内复合年增长率为 7.43%。撞击综合征，也称为肩部撞击，是一种常见的肌肉骨骼疾病，影响着全世界数百万人。当肩部肌腱受到压迫或刺激时，就会发生这种情况，导致疼痛、活动范围减少和功能受限。全球撞击综合征市场包括该病症的诊断、治疗和疗法，近年来取得了显着增长。撞击症候群市场包括一系列产品和服务，包括X光、MRI扫描和身体检查等诊断工具，以及物理治疗、皮质类固醇注射和微创手术等非手术和手术治疗。推动该市场成长的关键因素包括撞击综合征发病率的上升、对肌肉骨骼疾病的认识的提高以及医疗技术的进步。在全球范围内，撞击症候群的盛行率呈上升趋势，主要原因是人口老化以及不良姿势和久坐行为等生活方式因素。随着越来越多的人因肩部疼痛和不适而寻求医疗救治，对诊断和治疗方案的需求也日益增长。微创手术技术在治疗撞击症候群方面已越来越受欢迎。与传统开放式手术相比，关节镜检查等手术恢復时间更短，术后疼痛减轻，推动了这些技术的需求。富血小板血浆 (PRP) 和干细胞疗法等再生疗法正在成为治疗撞击症候群的潜在疗法。这些疗法旨在刺激人体的自然癒合过程，提供一种侵入性较小且可能更有效的治疗选择。 COVID-19 疫情加速了远距医疗和远端监控在医疗保健领域的应用。这些技术使得患者能够更轻鬆地获得撞击症候群的咨询和后续护理，提供便利、高效的医疗保健解决方案。随着人们认识的提高、医疗技术的进步以及该病患病率的上升，全球撞击症候群市场有望实现成长。虽然存在报销问题和竞争等挑战，但个人化医疗、新兴市场、合作研究和数位健康解决方案的机会为市场带来了光明的未来。随着研究和创新的不断进步，撞击症候群市场有可能为全球患者提供更好的护理和治疗结果。

主要市场驱动因素

撞击症候群盛行率上升推动全球撞击症候群市场发展

主要市场挑战

认识不足和误诊

主要市场趋势

技术进步

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第 5 章：全球撞击症候群市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依肌肉骨骼疾病类型（骨关节炎、类风湿性关节炎、骨质疏鬆症、背部和颈部疼痛、肩部撞击症候群、膝盖疼痛和疾病、髋部疼痛和疾病、创伤和骨折、运动伤害、其他）
  • 依诊断及影像技术（X 光、磁振造影 (MRI)、电脑断层扫描 (CT)、超音波、关节镜检查、其他）
  • 按治疗方式（药物和手术介入）
  • 按最终使用者（医院和诊所、门诊护理中心、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第 6 章：北美撞击症候群市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 加拿大
  • 墨西哥

第 7 章：欧洲撞击症候群市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太撞击症候群市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲撞击症候群市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲撞击症候群市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如果有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Bioventus LLC
• Orthofix Medical Inc.
• Breg, Inc.
• ConMed Corporation
• Ossur hf.
• Arthrex, Inc.
• Globus Medical, Inc.
• NuVasive, Inc.
• Stryker Corporation
• Medtronic plc

第 15 章：策略建议

Global Impingement Syndrome Market was valued at USD 8.12 Billion in 2024 and is expected to reach USD 12.51 Billion by 2030 with a CAGR of 7.43% during the forecast period. Impingement syndrome, also known as shoulder impingement, is a common musculoskeletal condition that affects millions of people worldwide. It occurs when the tendons in the shoulder become compressed or irritated, leading to pain, reduced range of motion, and functional limitations. The global impingement syndrome market, which includes diagnostics, treatments, and therapies for this condition, has witnessed significant growth in recent years. The impingement syndrome market comprises a range of products and services, including diagnostic tools such as X-rays, MRI scans, and physical examinations, as well as non-surgical and surgical treatments like physical therapy, corticosteroid injections, and minimally invasive procedures. Key factors driving the growth of this market include the rising incidence of impingement syndrome, increasing awareness about musculoskeletal disorders, and advancements in medical technology. The prevalence of impingement syndrome is on the rise globally, primarily due to aging populations and lifestyle factors such as poor posture and sedentary behavior. As more individuals seek medical attention for shoulder pain and discomfort, the demand for diagnosis and treatment options is growing. Minimally invasive surgical techniques have gained popularity in the treatment of impingement syndrome. Procedures like arthroscopy offer quicker recovery times and reduced post-operative pain compared to traditional open surgery, driving demand for these techniques. Regenerative therapies such as platelet-rich plasma (PRP) and stem cell therapy are emerging as potential treatments for impingement syndrome. These therapies aim to stimulate the body's natural healing processes, offering a less invasive and potentially more effective treatment option. The COVID-19 pandemic accelerated the adoption of telemedicine and remote monitoring in healthcare. These technologies have made it easier for patients to access consultations and follow-up care for impingement syndrome, providing a convenient and efficient healthcare solution. The global impingement syndrome market is poised for growth, driven by increasing awareness, advancements in medical technology, and a rising prevalence of the condition. While challenges such as reimbursement issues and competition exist, opportunities in personalized medicine, emerging markets, collaborative research, and digital health solutions offer a promising future for the market. As research and innovation continue to advance, the impingement syndrome market has the potential to provide better care and outcomes for patients worldwide.

Key Market Drivers

Rising Prevalence of Impingement Syndrome is Driving the Global Impingement Syndrome Market

Impingement syndrome, also known as shoulder impingement, is a common orthopedic condition that affects millions of people worldwide. This condition occurs when the tendons or bursa in the shoulder become compressed or irritated, leading to pain, limited range of motion, and decreased quality of life. In recent years, the global Impingement Syndrome market has witnessed significant growth due to the rising prevalence of this condition and the increasing demand for effective treatment options.

Impingement syndrome primarily affects the shoulder joint, making it a common orthopedic ailment. It is often seen in individuals who engage in repetitive overhead activities, such as athletes, manual laborers, and individuals who perform tasks that require constant shoulder use. The aging population also plays a significant role in the increasing prevalence of this condition, as degenerative changes in the shoulder joint can make individuals more susceptible to impingement. Moreover, lifestyle factors such as poor posture, sedentary habits, and obesity contribute to the development of Impingement Syndrome. As these risk factors become more prevalent in modern society, the number of people diagnosed with shoulder impingement continues to rise. According to a study, "Shoulder impingement syndrome: impingement view and arthrography study based on 100 cases", aprospective evaluation was conducted to assess the combination of shoulder impingement views and arthrography in patients with chronic shoulder pain. A total of 523 patients with chronic shoulder pain underwent X-rays using both conventional and impingement views. Among them, 100 patients (mean age 62) were found to have subacromial bony spurs on the impingement view and underwent arthrography. These patients were divided into two groups based on the degree of spur formation, specifically whether the spur size exceeded half the acromial width, measured from the outer margin to the acromioclavicular joint. Of the 100 subacromial spurs identified on the impingement view, only 18 were visible on the conventional view, as assessed by an independent radiologist. Arthrography revealed 35 cases of rotator cuff tears, and the size of the bony spur was significantly associated with the occurrence of rotator cuff tears (P < 0.02).

Key Market Challenges

Limited Awareness and Misdiagnosis

One of the most significant obstacles in the impingement syndrome market is the limited awareness of the condition, both among the general public and healthcare professionals. Many individuals experiencing shoulder or hip pain may not immediately recognize the symptoms as indicative of impingement syndrome, often attributing the discomfort to general wear and tear, muscle strain, or other non-specific causes. This lack of awareness can lead to delayed diagnoses and subsequent delays in appropriate treatment, which can worsen the condition and increase the complexity of treatment. Additionally, healthcare providers may overlook the symptoms as they may present similarly to other musculoskeletal disorders, such as tendonitis or rotator cuff injuries, further complicating the diagnosis. The absence of early intervention can lead to chronic pain, impaired mobility, and a greater risk of developing secondary complications, ultimately contributing to higher healthcare costs due to prolonged treatment and rehabilitation needs. Increased education and awareness, particularly among general practitioners and physical therapists, are essential for timely identification and intervention.

Key Market Trends

Technological Advancements

Technological advancements have revolutionized healthcare across the globe, and the field of orthopedics is no exception. One area where these advancements are making a significant impact is in the treatment and management of Impingement Syndrome. This condition, characterized by pain and restricted movement in the shoulder, has traditionally been treated through conservative measures like physical therapy and anti-inflammatory medications. However, the integration of innovative technologies into the medical field is now opening up new avenues for diagnosis and treatment, transforming the global Impingement Syndrome market. In January 2023, Orthofix Medical Inc. and SeaSpine Holdings Corporation have successfully completed their previously announced merger of equals, following approval from the stockholders of both companies during their respective special meetings. A remarkable 99% of SeaSpine common shares and 98% of Orthofix common shares were voted in favor of the merger.

The advent of high-resolution imaging technologies like magnetic resonance imaging (MRI) and ultrasound has greatly improved the accuracy of diagnosing Impingement Syndrome. These tools allow healthcare professionals to visualize the shoulder joint and surrounding tissues in detail, enabling more precise diagnosis and treatment planning. Three-dimensional modeling techniques have emerged as powerful tools in the diagnosis of Impingement Syndrome. By creating detailed 3D models of the shoulder joint, doctors can better understand the structural issues contributing to impingement and plan interventions accordingly.

Key Market Players

• Bioventus LLC
• Orthofix Medical Inc.
• Breg, Inc.
• ConMed Corporation
• Ossur hf.
• Arthrex, Inc.
• Globus Medical, Inc.
• NuVasive, Inc.
• Stryker Corporation
• Medtronic plc

Report Scope:

In this report, the Global Impingement Syndrome Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Impingement Syndrome Market, By Type of Musculoskeletal Disorder:

• Osteoarthritis
• Rheumatoid Arthritis
• Osteoporosis
• Back and Neck Pain
• Shoulder Impingement Syndrome
• Knee Pain and Disorders

Impingement Syndrome Market, By Diagnosis and Imaging Techniques:

• X-ray
• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT) Scan
• Ultrasound
• Arthroscopy
• Others

Impingement Syndrome Market, By Treatment Modalities:

• Medications
• Surgical Interventions

Impingement Syndrome Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Impingement Syndrome Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Impingement Syndrome Market.

Available Customizations:

Global Impingement Syndrome market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Impingement Syndrome Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type of Musculoskeletal Disorder (Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Back and Neck Pain, Shoulder Impingement Syndrome, Knee Pain and Disorders, Hip Pain and Disorders, Trauma and Fracture, Sports Injuries, Others)
  • 5.2.2. By Diagnosis and Imaging Techniques (X-ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Ultrasound, Arthroscopy, Others)
  • 5.2.3. By Treatment Modalities (Medications and Surgical Interventions)
  • 5.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Impingement Syndrome Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type of Musculoskeletal Disorder
  • 6.2.2. By Diagnosis and Imaging Techniques
  • 6.2.3. By Treatment Modalities
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Impingement Syndrome Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type of Musculoskeletal Disorder
      • 6.3.1.2.2. By Diagnosis and Imaging Techniques
      • 6.3.1.2.3. By Treatment Modalities
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Impingement Syndrome Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type of Musculoskeletal Disorder
      • 6.3.2.2.2. By Diagnosis and Imaging Techniques
      • 6.3.2.2.3. By Treatment Modalities
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Impingement Syndrome Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type of Musculoskeletal Disorder
      • 6.3.3.2.2. By Diagnosis and Imaging Techniques
      • 6.3.3.2.3. By Treatment Modalities
      • 6.3.3.2.4. By End User

7. Europe Impingement Syndrome Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type of Musculoskeletal Disorder
  • 7.2.2. By Diagnosis and Imaging Techniques
  • 7.2.3. By Treatment Modalities
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Impingement Syndrome Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type of Musculoskeletal Disorder
      • 7.3.1.2.2. By Diagnosis and Imaging Techniques
      • 7.3.1.2.3. By Treatment Modalities
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Impingement Syndrome Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type of Musculoskeletal Disorder
      • 7.3.2.2.2. By Diagnosis and Imaging Techniques
      • 7.3.2.2.3. By Treatment Modalities
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Impingement Syndrome Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type of Musculoskeletal Disorder
      • 7.3.3.2.2. By Diagnosis and Imaging Techniques
      • 7.3.3.2.3. By Treatment Modalities
      • 7.3.3.2.4. By End User
  • 7.3.4. France Impingement Syndrome Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type of Musculoskeletal Disorder
      • 7.3.4.2.2. By Diagnosis and Imaging Techniques
      • 7.3.4.2.3. By Treatment Modalities
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Impingement Syndrome Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type of Musculoskeletal Disorder
      • 7.3.5.2.2. By Diagnosis and Imaging Techniques
      • 7.3.5.2.3. By Treatment Modalities
      • 7.3.5.2.4. By End User

8. Asia-Pacific Impingement Syndrome Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type of Musculoskeletal Disorder
  • 8.2.2. By Diagnosis and Imaging Techniques
  • 8.2.3. By Treatment Modalities
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Impingement Syndrome Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type of Musculoskeletal Disorder
      • 8.3.1.2.2. By Diagnosis and Imaging Techniques
      • 8.3.1.2.3. By Treatment Modalities
      • 8.3.1.2.4. By End User
  • 8.3.2. India Impingement Syndrome Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type of Musculoskeletal Disorder
      • 8.3.2.2.2. By Diagnosis and Imaging Techniques
      • 8.3.2.2.3. By Treatment Modalities
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Impingement Syndrome Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type of Musculoskeletal Disorder
      • 8.3.3.2.2. By Diagnosis and Imaging Techniques
      • 8.3.3.2.3. By Treatment Modalities
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Impingement Syndrome Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type of Musculoskeletal Disorder
      • 8.3.4.2.2. By Diagnosis and Imaging Techniques
      • 8.3.4.2.3. By Treatment Modalities
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Impingement Syndrome Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type of Musculoskeletal Disorder
      • 8.3.5.2.2. By Diagnosis and Imaging Techniques
      • 8.3.5.2.3. By Treatment Modalities
      • 8.3.5.2.4. By End User

9. South America Impingement Syndrome Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type of Musculoskeletal Disorder
  • 9.2.2. By Diagnosis and Imaging Techniques
  • 9.2.3. By Treatment Modalities
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Impingement Syndrome Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type of Musculoskeletal Disorder
      • 9.3.1.2.2. By Diagnosis and Imaging Techniques
      • 9.3.1.2.3. By Treatment Modalities
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Impingement Syndrome Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type of Musculoskeletal Disorder
      • 9.3.2.2.2. By Diagnosis and Imaging Techniques
      • 9.3.2.2.3. By Treatment Modalities
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Impingement Syndrome Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type of Musculoskeletal Disorder
      • 9.3.3.2.2. By Diagnosis and Imaging Techniques
      • 9.3.3.2.3. By Treatment Modalities
      • 9.3.3.2.4. By End User

10. Middle East and Africa Impingement Syndrome Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type of Musculoskeletal Disorder
  • 10.2.2. By Diagnosis and Imaging Techniques
  • 10.2.3. By Treatment Modalities
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Impingement Syndrome Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type of Musculoskeletal Disorder
      • 10.3.1.2.2. By Diagnosis and Imaging Techniques
      • 10.3.1.2.3. By Treatment Modalities
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Impingement Syndrome Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type of Musculoskeletal Disorder
      • 10.3.2.2.2. By Diagnosis and Imaging Techniques
      • 10.3.2.2.3. By Treatment Modalities
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Impingement Syndrome Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type of Musculoskeletal Disorder
      • 10.3.3.2.2. By Diagnosis and Imaging Techniques
      • 10.3.3.2.3. By Treatment Modalities
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Bioventus LLC
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Orthofix Medical Inc.
• 14.3. Breg, Inc.
• 14.4. ConMed Corporation
• 14.5. Ossur hf.
• 14.6. Arthrex, Inc.
• 14.7. Globus Medical, Inc.
• 14.8. NuVasive, Inc.
• 14.9. Stryker Corporation
• 14.10. Medtronic plc

15. Strategic Recommendations